Rosanne M. Orr
- Co-authors
- LR KellandAdolfo Rivero‐MüllerGeorge E.N. KassMiloslav DobrotaLena Ruíz-AzuaraAndrea De Vizcaya‐RuízPhyllis M. GoddardTerry Beck
- Topics
- Metal complexes synthesis and properties (4 papers)Chronic Myeloid Leukemia Treatments (3 papers)Ferrocene Chemistry and Applications (2 papers)
- Journals
- Journal of Medicinal ChemistryBritish Journal of CancerJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United KingdomUnited StatesMexico
In The Last Decade
Rosanne M. Orr
15 papers receiving 420 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 244
- Oncology 187
- Organic Chemistry 99
- Inorganic Chemistry 35
- Genetics 28
Countries citing papers authored by Rosanne M. Orr
This map shows the geographic impact of Rosanne M. Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosanne M. Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosanne M. Orr more than expected).
Fields of papers citing papers by Rosanne M. Orr
This network shows the impact of papers produced by Rosanne M. Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosanne M. Orr. The network helps show where Rosanne M. Orr may publish in the future.
Co-authorship network of co-authors of Rosanne M. Orr
This figure shows the co-authorship network connecting the top 25 collaborators of Rosanne M. Orr. A scholar is included among the top collaborators of Rosanne M. Orr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosanne M. Orr. Rosanne M. Orr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 25 | |
| 3 | Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival. | 29 |
| 4 | Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision. | 62 |
| 5 | 123 | |
| 6 | 98 | |
| 7 | 3 | |
| 8 | Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. | 29 |
| 9 | 2'-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2'-deoxyadenosine resistance in lymphoid cell lines | 14 |
| 10 | 17 | |
| 11 | Evaluation of novel platinum (II), and platinum (IV) ammine/amine complexes in L1210 murine leukaemia cell lines sensitive and resistant to cisplatin and tetraplatin | 2 |
| 12 | 17 | |
| 13 | 1 | |
| 14 | 10 | |
| 15 | Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY). | 3 |
About Rosanne M. Orr
Rosanne M. Orr is a scholar working on Oncology, Hematology and Genetics, having authored 15 papers that have together received 438 indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Ferrocene Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (187 citations), Molecular Biology (244 citations) and Organic Chemistry (99 citations). Rosanne M. Orr has collaborated with scholars based in United Kingdom, United States and Mexico. Frequent co-authors include LR Kelland, Adolfo Rivero‐Müller, George E.N. Kass, Miloslav Dobrota, Lena Ruíz-Azuara, Andrea De Vizcaya‐Ruíz, Phyllis M. Goddard, Terry Beck, Florence I. Raynaud and Ian Judson. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.